Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY:
Remifentanil PCIA is a valuable analgesic strategy whenever regional analgesia is contraindicated. Using it as first line strategy seems to be contraindicated because of significant respiratory side-effects to the mother. Whenever used advanced and continuous monitoring using capnography, saturation monitoring and one-to-one midwifery care are mandatory!
|
Authors | Marc Van de Velde |
Journal | Current opinion in anaesthesiology
(Curr Opin Anaesthesiol)
Vol. 28
Issue 3
Pg. 237-9
(Jun 2015)
ISSN: 1473-6500 [Electronic] United States |
PMID | 25827284
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anesthetics, Intravenous
- Piperidines
- Remifentanil
|
Topics |
- Administration, Intravenous
- Adult
- Analgesia, Obstetrical
(methods)
- Analgesia, Patient-Controlled
(methods)
- Anesthetics, Intravenous
(administration & dosage)
- Female
- Humans
- Piperidines
(administration & dosage)
- Pregnancy
- Remifentanil
|